RituximabCOVID-19 infection: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1846卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92531-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：283 / 283

相关论文

共 50 条

[21] RituximabCOVID-19 infection: case report
Reactions Weekly, 2022, 1928 (1) : 324 - 324
[22] RituximabCOVID-19 infection: case report
Reactions Weekly, 2022, 1927 (1) : 464 - 464
[23] RituximabCOVID-19 infection
Reactions Weekly, 2024, 2003 (1) : 730 - 730
[24] RituximabCOVID-19 infection
Reactions Weekly, 2024, 2009 (1) : 519 - 519
[25] Cyclophosphamide/rituximabCOVID-19 infection: case report
Reactions Weekly, 2021, 1885 (1) : 170 - 170
[26] Azathioprine/rituximabCOVID-19 reinfection: 2 case reports
Reactions Weekly, 2025, 2053 (1) : 66 - 66
[27] Fingolimod/rituximabCOVID-19 and reduced humoral immunity: 3 case reports
Reactions Weekly, 2023, 1968 (1) : 143 - 143
[28] RituximabCOVID-19: case report
Reactions Weekly, 2021, 1836 (1) : 686 - 686
[29] Methotrexate/prednisolone/rituximabCOVID-19 pneumonia: 2 case reports
Reactions Weekly, 2021, 1856 (1) : 267 - 267
[30] Ocrelizumab/rituximabCOVID-19 infection
Reactions Weekly, 2024, 2005 (1) : 663 - 663

← 1 2 3 4 5 →